DrugCite
Search

LAMIVUDINE AND ZIDOVUDINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lamivudine And Zidovudine Adverse Events Reported to the FDA Over Time

How are Lamivudine And Zidovudine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lamivudine And Zidovudine is flagged as the suspect drug causing the adverse event.

Most Common Lamivudine And Zidovudine Adverse Events Reported to the FDA

What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?

Drug Exposure During Pregnancy
324 (8.54%)
Premature Baby
93 (2.45%)
Stillbirth
69 (1.82%)
Abortion Spontaneous
63 (1.66%)
Anaemia
56 (1.48%)
Congenital Anomaly
56 (1.48%)
Abdominal Distension
41 (1.08%)
Cardiac Murmur
41 (1.08%)
Maternal Drugs Affecting Foetus
40 (1.05%)
Ventricular Septal Defect
40 (1.05%)
Cryptorchism
37 (.98%)
Show More Show More
Polydactyly
35 (.92%)
Abdominal Hernia
33 (.87%)
Pregnancy
32 (.84%)
Small For Dates Baby
30 (.79%)
Pancytopenia
29 (.76%)
Abortion Induced
27 (.71%)
Pyrexia
26 (.69%)
Neutropenia
25 (.66%)
Trisomy 21
24 (.63%)
Sepsis
22 (.58%)
Intra-uterine Death
21 (.55%)
Hydrocephalus
19 (.5%)
Premature Labour
18 (.47%)
Vomiting
18 (.47%)
Caesarean Section
17 (.45%)
Alanine Aminotransferase Increased
16 (.42%)
Aspartate Aminotransferase Increase...
16 (.42%)
Confusional State
16 (.42%)
Diarrhoea
16 (.42%)
Dyspnoea
16 (.42%)
Oesophageal Atresia
16 (.42%)
Rash
16 (.42%)
Respiratory Distress
16 (.42%)
Thrombocytopenia
16 (.42%)
Nausea
15 (.4%)
Coma
14 (.37%)
Convulsion
14 (.37%)
Lactic Acidosis
14 (.37%)
Pain
14 (.37%)
Polyhydramnios
14 (.37%)
Renal Failure
14 (.37%)
Haemoglobin Decreased
13 (.34%)
Malaise
13 (.34%)
Premature Rupture Of Membranes
13 (.34%)
Cardiac Malposition
12 (.32%)
Foetal Growth Retardation
12 (.32%)
Hyperlactacidaemia
12 (.32%)
Immune Reconstitution Syndrome
12 (.32%)
Neonatal Respiratory Distress Syndr...
12 (.32%)
Pneumothorax
12 (.32%)
Spine Malformation
12 (.32%)
Abdominal Pain
11 (.29%)
Congenital Choroid Plexus Cyst
11 (.29%)
Drug Interaction
11 (.29%)
Dysmorphism
11 (.29%)
Hypoglycaemia
11 (.29%)
Jaundice
11 (.29%)
Leukopenia
11 (.29%)
Myocardial Infarction
11 (.29%)
Neuropathy Peripheral
11 (.29%)
Platelet Count Decreased
11 (.29%)
Alpha 1 Foetoprotein Abnormal
10 (.26%)
Ascites
10 (.26%)
Atrial Septal Defect
10 (.26%)
Blood Lactate Dehydrogenase Increas...
10 (.26%)
Cleft Lip And Palate
10 (.26%)
Hemivertebra
10 (.26%)
Overdose
10 (.26%)
Alpha 1 Foetoprotein Increased
9 (.24%)
Bone Marrow Failure
9 (.24%)
Bradycardia
9 (.24%)
Encephalopathy
9 (.24%)
Foetal Distress Syndrome
9 (.24%)
Gastritis
9 (.24%)
Gastrointestinal Disorder
9 (.24%)
General Physical Health Deteriorati...
9 (.24%)
Hydrocele
9 (.24%)
Hypersensitivity
9 (.24%)
Liver Function Test Abnormal
9 (.24%)
Neonatal Disorder
9 (.24%)
Oedema Peripheral
9 (.24%)
Placental Disorder
9 (.24%)
Pruritus
9 (.24%)
Renal Failure Acute
9 (.24%)
Respiratory Disorder
9 (.24%)
Blood Creatine Phosphokinase Increa...
8 (.21%)
C-reactive Protein Increased
8 (.21%)
Congenital Foot Malformation
8 (.21%)
Cytolytic Hepatitis
8 (.21%)
Death
8 (.21%)
Double Outlet Right Ventricle
8 (.21%)
Headache
8 (.21%)
Hepatic Displacement
8 (.21%)
Hepatic Function Abnormal
8 (.21%)
Patent Ductus Arteriosus
8 (.21%)
Pneumonia
8 (.21%)
Talipes
8 (.21%)
Trisomy 18
8 (.21%)
Blood Alkaline Phosphatase Increase...
7 (.18%)
Blood Creatinine Increased
7 (.18%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lamivudine And Zidovudine

What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lamivudine And Zidovudine According to Those Reporting Adverse Events

Why are people taking Lamivudine And Zidovudine, according to those reporting adverse events to the FDA?

Hiv Infection
811
Drug Exposure During Pregnancy
357
Drug Use For Unknown Indication
99
Acquired Immunodeficiency Syndrome
53
Prophylaxis Against Hiv Infection
50
Antiretroviral Therapy
49
Show More Show More
Hiv Test Positive
41
Antiviral Treatment
24
Systemic Antiviral Treatment
18
Maternal Exposure Timing Unspecifie...
15
Maternal Exposure During Pregnancy
14
Antiviral Prophylaxis
13
Human Immunodeficiency Virus Transm...
13
Prophylaxis
11
Product Used For Unknown Indication
11
Ill-defined Disorder
8
Hiv Infection Cdc Category C3
3
Viral Infection
3
Accidental Exposure
3
Foetal Exposure During Pregnancy
2
Retroviral Infection
1
Hepatitis B Virus Test
1
Pregnancy
1
Adult T-cell Lymphoma/leukaemia
1
Pneumocystis Jiroveci Pneumonia
1
Pneumocystis Jiroveci Infection
1
Hiv Infection Cdc Category B2
1

Drug Labels

LabelLabelerEffective
CombivirStat Rx USA27-OCT-09
CombivirRebel Distributors Corp24-SEP-10
CombivirPD-Rx Pharmaceuticals, Inc.14-MAR-11
CombivirGlaxoSmithKline LLC14-MAR-11
TrizivirGlaxoSmithKline LLC13-JUL-11
Lamivudine And ZidovudinePD-Rx Pharmaceuticals, Inc.23-DEC-11
CombivirHHS/Program Support Center/Supply Service Center03-JAN-12
CombivirH.J. Harkins Company, Inc.02-FEB-12
Lamivudine And ZidovudineRebel Distributors Corp04-APR-12
Lamivudine And ZidovudineLupin Pharmaceuticals, Inc.24-APR-12
Lamivudine And ZidovudineAurobindo Pharma Limited15-MAY-12
Lamivudine And ZidovudineTeva Pharmaceuticals USA Inc21-MAY-12
TrizivirViiV Healthcare Company22-MAY-12
Lamivudine And ZidovudineH.J. Harkins Company, Inc.25-JUN-12
Lamivudine And ZidovudineSt Marys Medical Park Pharmacy29-AUG-12
CombivirViiV Healthcare Company16-JAN-13
Lamivudine And ZidovudineBryant Ranch Prepack18-JAN-13
CombivirREMEDYREPACK INC. 11-MAR-13
Lamivudine And ZidovudineREMEDYREPACK INC. 11-APR-13
Lamivudine And ZidovudineREMEDYREPACK INC. 11-APR-13
CombivirREMEDYREPACK INC. 23-APR-13
CombivirREMEDYREPACK INC. 23-APR-13
CombivirREMEDYREPACK INC. 23-APR-13

Lamivudine And Zidovudine Case Reports

What Lamivudine And Zidovudine safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lamivudine And Zidovudine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lamivudine And Zidovudine.